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A B S T R A C T
Lithium is a widely used mood-stabilizing agent; however, it causes a variety of cardiovascular side eﬀects
including sinus node dysfunction. In this study we explored the potential adverse eﬀects of lithium on cardiac
chronotropic responsiveness, atrial tissue histology and gene expression in rats that were chronically treated
with therapeutic doses of lithium. Male Wistar albino rats were given lithium chloride (2.5 g/kg) orally for 2 or
3 months. Following treatment, the atria were isolated and spontaneously beating rate and chronotropic re-
sponsiveness to β-adrenergic stimulation was evaluated in an organ bath. Development of cardiac ﬁbrosis was
examined by histological methods. The expression of atrial Col1a1 (collagen I, alpha 1) and β-arrestin2 was also
assessed using quantitative RT-PCR. Treatment with lithium induced a signiﬁcant hypo-responsiveness to
adrenergic stimulation (P < 0.001) and caused ﬁbrosis in the atrial tissue of treated rats. In addition, the ex-
pression of atrial Col1a1 mRNA was signiﬁcantly increased in atrial tissues of lithium-treated animals, while β-
arrestin2 mRNA expression did not show a signiﬁcant diﬀerence compared with control animals. Altogether,
these ﬁndings indicate that cardiac chronotropic hypo responsiveness and associated cardiac ﬁbrosis are side
eﬀects of chronic lithium treatment. Moreover, it seems that lithium treatment does not inﬂuence β-arrestin2
mRNA expression.
1. Introduction
Lithium has a long history of application as a ﬁrst-line agent in the
treatment of acute mania and prophylaxis of bipolar aﬀective disorder
(Belmaker, 2004). One to three percent of the world's population suﬀers
from bipolar disorder and lots of aﬀected individuals are on lithium
therapy (Chiu et al., 2013). Despite its eﬃcacy, diﬀerent side eﬀects
including heart-related problems have been reported for lithium. In-
deed, diverse cardiac abnormalities are known to be caused by lithium,
including cardiac conduction defects (sinus node dysfunction, sinus
bradycardia, premature atrial and ventricular contractions, atrioven-
tricular nodal block, cardiac dysrhythmias), electrocardiographic (ECG)
alterations, congenital heart disease and myocarditis (Anantha
Narayanan et al., 2015; Brady and Horgan, 1988; Moltedo et al., 2002;
Wellens et al., 1975).
Multiple molecular targets have been identiﬁed for lithium;
however, the exact mechanism of its actions remains unclear. Several
studies have proposed that lithium exerts some of its biochemical and
behavioral eﬀects through modulation of GPCR signaling, including
eﬀects on G protein levels or G protein coupling (Lenox and Hahn,
2000; Farhy Tselnicker et al., 2014). Regulation of β-arrestin-mediated
eﬀects, activity of PKC isozymes, and direct inhibition of glycogen
synthase kinase-3 (GSK-3) and inositol monophosphatase have also
been reported (Lenox and Hahn, 2000; O'Brien et al., 2011).
There is a proven link between chronic use of lithium and devel-
opment of renal interstitial ﬁbrosis (Walker et al., 2013). Development
of ﬁbrosis is known to cause organ dysfunction in a variety of diseases.
Indeed, renal ﬁbrosis that is caused by lithium is known to mediate, at
least in part, lithium's nephrotoxic eﬀects. Despite lithium's cardiac side
eﬀects, it is not known whether this drug can cause similar alterations
in heart tissue. Herein, we investigated cardiac chronotropic respon-
siveness following prolonged treatment of rats with lithium.
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Experiments were performed to examine potential development of
cardiac ﬁbrosis in lithium-treated animals. This was followed by ex-
amining the expression of collagen and β-arrestin2 genes in isolated
heart tissues.
2. Materials and methods
All materials and chemicals were purchased from Sigma (Pool, UK),
unless otherwise stated.
2.1. Animals
Thirty-one male Wistar albino rats weighing 250–280 g were ob-
tained from Department of Pharmacology in Tehran University of
Medical Sciences. Animals were housed in a controlled environment
(24 ± 2 °C, 50 ± 5% humidity) on a 12:12 h light/dark cycle with
free access to food and water. With a light/dark cycle of 12 h; at a
temperature of 22 °C. All animal procedures were in accordance with
‘Guide for the Care and Use of Laboratory Animals’ (NIH US publication
No 85-23, revised 1985) recommendations. Animals were randomly
assigned to the following groups: (I) saline for 2months, control); II)
lithium chloride (2.5 g/kg, for 2months); (III) lithium chloride (2.5 g/
kg, for 3months). Dose of lithium was chosen based on its therapeutic
dose in manic disorder in rat. To conﬁrm the achievement of ther-
apeutic plasma concentrations of lithium between 0.6 and 1.5 mmol/l
(Walker et al., 2013), we measured plasma lithium level after 1, 2 and
3months of treatment. Also time intervals (2 or 3months) were chosen
based on the comparative studies between human and rat and the
maximum time we were able to keep animals with minimum mortality.
Lithium chloride was dissolved in sterile saline and all the groups re-
ceived either the drug or saline by gavage once daily.
2.2. Preparations of isolated atria
In order to study the chronotropic responsiveness to adrenergic
stimulation, the spontaneously beating right atria were used. On day
61, after thoracotomy under deep anesthesia (ketamine 100mg/kg and
xylazine 8mg/kg, intraperitoneally), the hearts were quickly excised
(n=10, 5 rats of each control and 2-mo lithium treated groups) and
placed in a dissection dish ﬁlled with cold oxygenated physiological salt
solution of the following composition (mM):NaCl,112.0; KCl, 5; CaCl2,
1.8; MgCl2, 1.0; NaH2PO4, 0.5;KH2PO4, 0.5; NaHCO3, 25.0; glucose,
10.0; and EDTA, 0.004. Then, the right atria were carefully dissected
and mounted vertically under isometric tension of 1 g force in a 20-ml
organ bath chamber (Power lab system, AD Instrument, Australia).The
organ bath chamber was ﬁlled with physiological salt solution which
was gassed continuously with 95% O2 and 5% CO2 (pH 7.4) and
maintained at 37.0 ± 1 °C. Before evaluation of the spontaneous con-
tractions, an equilibration period of 30min was considered. The signals
were digitized and displayed on a PowerLab system. The responsiveness
of isolated atria to adrenergic stimulation was assessed by addition of
cumulative concentrations of isoproterenol, a full agonist for β-ARs,
(10_10 to 10_5 M) to the organ bath (Jazaeri et al., 2013).
2.3. Histologic assessment of atria
Isolated atria were ﬁxed in 10% neutral buﬀered formalin overnight
at room temperature (n=6, 3 rats of each control and 2-mo lithium
treated groups). Following the initial ﬁxation, tissues were progres-
sively dehydrated with increasing concentrations of ethanol, and em-
bedded in paraﬃn. Four micrometer sections were stained with he-
matoxylin and eosin (H&E) for histomorphological characterization or
with Masson's trichrome for visualizing collagenous and elastic tissue.
Stained sections were examined and scored by two pathologists using a
light microscope under double blind conditions.
2.4. Real-time PCR
2.4.1. RNA extraction and reverse transcription
Animals' atria were isolated as described previously and immersed
in liquid nitrogen (n=12, 4 rats in each group).Total RNA was ex-
tracted using RNeasy Fibrous Tissue Mini Kit (QIAGEN, Germany) fol-
lowing the manufacturer's directions. Genomic DNA was removed using
DNase (QIAGEN, Germany).The concentration and purity of RNA was
determined using spectrophotometer by measuring the absorbance at
260 nm and ratio at 260 nm/280 nm (nucleotide/protein), respectively.
The isolated RNA had absorbance 260 nm/280 nm ratios greater than
or equal to 1.8. To produce ﬁrst-strand cDNA, DNase-treated RNAs
were reverse transcribed using a Prime Script RT reagent Kit (TAKARA,
Japan) based on manufacturer's protocol.
2.4.2. Quantitative real time polymerase chain reaction
Quantitative RT-PCR (qRT-PCR) was performed with a Rotor-Gene
machine for evaluation of β-arrestin2 and collagen type 1, alpha1
(COL1A1) expressions in atria in control and lithium treated rats.
Oligonucleotide primers used for PCR ampliﬁcation were as follows:
Rat β-arrestin2, Forward: 5′-CGTGGTGCTTGTGGACCCTG-3′; Reverse:
5′-CCTGGTAGGTGGCGATGAAC-3′. Rat collagen type 1, alpha1
(COL1A1), Forward: 5′-CTTCGTGTAAACTCCCTCCATCC-3′; Reverse:
5′-AAGTCCATGTGAAATTGTCTCCCA-3′. Rat GPDH, Forward: 5′-TGC
ACCACCAACTGCTTAG-3′; Reverse: 5′-GGATGCAGGGATGATGTTC-3′.
Total volume of the reaction was 10 μl which comprised of 0.2 μmol
of each forward and reverse primers, 5 μl of SYBR Premix Ex Taq 2X
(TAKARA) and 1 μl of cDNA template. The holding stage (95 °C for 5 s)
was followed by the cycling stage (denaturation 10 s at 95 °C, annealing
20 s at 60 °C, and extension/elongation 30 s at 72 °C) and the number of
cycles was 40. For analyzing data, we used the competitive critical
threshold (ΔΔCT) method in which the RNA of β-arrestin2 as well as
COL1A1 were adjusted to RNA of GPDH.
2.5. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0
(GraphPad Software, Inc., San Diego, CA, USA). The results were ex-
pressed as mean ± SEM. Chronotropic study was analyzed using
Student's t-test. P values < 0.05 were considered statistically sig-
niﬁcant.
3. Results
3.1. Measurement of plasma levels of lithium
To conﬁrm that treated animals have reached therapeutic plasma
concentrations of lithium (between 0.6 and 1.5mmol/l) (Walker et al.,
2013), we measured plasma lithium levels after 1, 2 and 3months of
treatment. The results were as follows (values are mean ± SEM):
1month: 0.65 ± 0.06mmol/lit; 2 months: 0.7 ± 0.1 mmol/lit;
3 months: 0.67 ± 0.07mmol/lit.
3.2. Analysis of chronotropic responses following lithium treatment
We ﬁrst examined the potential eﬀects of lithium on cardiac
chronotropic responses using isolated rat atria. Our data showed that
chronotropic responses to isoproterenol, a β-adrenergic agonist, were
signiﬁcantly impaired in isolated atria following 2months lithium
treatment (P < 0.001, Fig. 1a). Moreover, a signiﬁcant diﬀerence in
the EC50 of isoproterenol between lithium treated atria
(logEC50=−7.501 ± 0.05) was observed compared with control
atria (logEC50=−8.966 ± 0.09). However, there was no signiﬁcant
diﬀerence in the maximum response (Rmax) to isoproterenol in lithium
treated group in comparison with control group (Fig. 1a).
Moreover, chronotropic responsiveness data were iteratively ﬁtted
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to the Hill equation, obtaining curve parameter estimates for mid-point
location (EC50), upper asymptote of the observed maximal eﬀect and
Hill slope. GraphPad Prism software was used to ﬁt the data. Fig. 1b
shows the sigmoidal curve that is obtained with the Hill model.
3.3. Development of atrial ﬁbrosis in lithium-treated rats
Considering the impaired chronotropic responsiveness to β-adre-
nergic agonist in lithium-treated animals, we then examined the eﬀects
of treatment on development of cardiac ﬁbrosis and inﬂammation using
two diﬀerent histological methods, H&E and Masson's trichrome
staining (Fig. 2). No evidence of ﬁbrosis or inﬂammation was seen in
stained sections from control animals (Fig. 2A). However, animals that
had received lithium for 2 or 3months showed profound changes in
cardiac histology. The most prominent change in tissue histology was
development of ﬁbrosis (excess ﬁbrous connective tissue), as seen in the
areas indicated by the arrows in Fig. 2 B and C. Masson's trichrome
staining better reveled the extent and location of these ﬁbrotic changes.
The histopathological features of 3 observed sections in each group
were as follows; in 3months lithium treatment group: minimal inter-
stitial ﬁbrosis, mild focal interstitial ﬁbrosis, negative for ﬁbrosis; in
2months lithium treatment: mild focal interstitial ﬁbrosis, sub-
endocardial ﬁbrosis, negative for ﬁbrosis (Fig. 2).
3.4. Atrial Col1a1 and β-arrestin2 expression following lithium treatment
Development of ﬁbrosis is generally associated with increased ac-
tivity of ﬁbroblasts and enhanced expression of extracellular matrix
(ECM)-related genes. Collagen type 1, a major ECM component, is
composed of three polypeptides which are encoded by collagen type 1
alpha 1 (Col1a1) and alpha 2 (Col1a2) genes. To examine whether
histological ﬁbrosis is associated with gene expression alterations we
evaluated the expression of Col1a1 gene in isolated rat atria. Real-time
PCR analysis of mRNA levels showed signiﬁcant upregulation of Col1a1
in the atria of lithium-treated rats, both in 2-months and 3-months
treated groups, compared with controls (Fig. 3a). Moreover, con-
sidering that beta-adrenergic receptor activity is regulated by beta-ar-
restin molecules, we asked whether lithium treatment might have af-
fected beta-arrestin gene expression. Real-time PCR analysis for β-
arrestin2 mRNA did not show any signiﬁcant diﬀerences in expression
in atria of lithium-treated rats compared with control animals (Fig. 3A).
While we did not analyze β-arrestin2 protein levels, nonetheless these
ﬁndings diminish the likelihood of β-arrestin2 involvement, at least at
the transcriptional level, in the observed eﬀects.
4. Discussion
The mood stabilizer lithium is primarily used in the management of
bipolar disorder, a chronic mental illness and an important cause of
disability worldwide (Licht, 2012). Prolonged treatment with lithium is
associated with various side eﬀects including renal damage as well as
cardiac problems. In the current study, we investigated the eﬀects of
lithium treatment on heart's chronotropic response as well as atrial
tissue histology and expression of relevant genes. Our results demon-
strated a signiﬁcant decrease in beta-adrenergic response in rats that
had received a therapeutic dose of the drug over a period of 2 to
3months. Histological analyses showed atrial ﬁbrosis in treated ani-
mals. Molecular assays revealed enhanced levels of collagen, but not
beta-arrestin, transcripts in cardiac tissues obtained from treated ani-
mals.
Sinus node dysfunction and sinus bradycardia have been reported
following long-term use of lithium, both in therapeutic and toxic serum
levels (Moltedo et al., 2002; Wellens et al., 1975; Freeman and
Freeman, 2006; Oudit et al., 2007; Livingstone and Rampes, 2006).
Various intrinsic and/or extrinsic factors have been suggested to be
involved in lithium-induced sinus node dysfunction, including degree of
cardiac sympathetic and parasympathetic tone, lithium-induced
blockade of cardiac sodium channels and decreased intrinsic sinus rate
due to age-dependent occurrence of interstitial ﬁbrosis (Oudit et al.,
2007). In the current study, following experiments that revealed de-
creased beta-adrenergic response in lithium-treated animals, we ex-
amined the eﬀects of lithium on development of interstitial ﬁbrosis in
atrial tissue. This research direction was partly based on the results of
studies performed in the context of lithium induced nephropathy. In-
deed, several studies have shown that long-term lithium treatment can
lead to development of renal interstitial ﬁbrosis, both in animal models
and in human cases (Walker et al., 2013; Marti et al., 2016; Rao et al.,
1981). This drug-induced interstitial ﬁbrosis is believed to interfere
with renal tubular function, leading to the widely recognized lithium
side eﬀect, i.e. renal damage. Likewise, cardiac ﬁbrosis might have
pathological outcomes, predisposing individuals to cardiac arrhythmia
due to diminished conduction velocity, conduction blocks, or impaired
cardiomyocyte-ﬁbroblast couplings (Lin et al., 2016). Sinoatrial node
Fig. 1a. Concentration-dependent responsiveness of isolated right atria to iso-
proterenol (β-adrenergic stimulation) in control or 2months lithium-treated
rats. Chronotropic studies were obtained on spontaneously beating atrium.
Results are shown as mean ± SEM. 5 rats were used in each group. (*P < 0.05
comparison between atrial responses in concentration 10–7.5 M of isoproterenol
in two groups, **P < 0.01 compared between atrial responses in concentration
10–8.5 M of isoproterenol in two groups, ***P < 0.001 compared between at-
rial responses in concentration 10−8 M of isoproterenol in two groups, Student's
t-test).










Fig. 1b. Concentration-dependent responsiveness of isolated right atria to iso-
proterenol (β-adrenergic stimulation) in control or 2months lithium-treated
rats. Chronotropic studies were obtained on spontaneously beating atrium.
Results are shown as mean ± SEM. 5 rats were used in each group. (*P < 0.05
comparison between atrial responses in concentration 10–7.5 M of isoproterenol
in two groups, **P < 0.01 compared between atrial responses in concentration
10–8.5 M of isoproterenol in two groups, ***P < 0.001 compared between at-
rial responses in concentration 10−8 M of isoproterenol in two groups, Results
obtained from an iterative ﬁtting procedure to the Hill equation in a nonlinear
model).
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(SAN) which is composed of clusters of specialized cardiomyocytes is
enmeshed within strands of connective tissue, mostly a combination of
collagen, elastin and ﬁbroblasts. Development of ﬁbrosis within the
SAN is known to aﬀect SAN's function and it might lead to tachycardia-
bradycardia arrhythmias and cardiac arrest (Csepe et al., 2015). Our
histological analyses showed the occurrence of ﬁbrosis in atrial tissue of
lithium-exposed animals. Our histological study was descriptive,
nonetheless it could clearly display the presence of ﬁbrosis in the H&E
and speciﬁc stains, enabling us to provide a qualitative comparison
between groups of animals. Consistent with qualitative histology,
quantitative real-time PCR analyses on cardiac tissues revealed statis-
tically signiﬁcant upregulation of collagen (Col1a1) gene in lithium-
treated hearts.
The observed association between reduced chronotropic response
and atrial ﬁbrosis suggests, but it does not conﬁrm, a causal link be-
tween these two phenomena. Indeed, it is possible that lithium might
have led to altered chronotropic response and atrial ﬁbrosis through
independent mechanisms. Establishment of a cause and eﬀect relation
between these phenomena would require beta-adrenergic response
analysis in lithium-treated animals in the presence of an intervention
that blocks the induction of ﬁbrosis. Nonetheless, pervious reports in-
dicating that intranodal ﬁbrosis is associated with lower heart rates
lend some support, albeit indirect, to a link between these two eﬀects
(Csepe et al., 2015).
It has been reported that lithium exerts some of its eﬀects through
direct targeting of G protein-coupled receptor (GPCR) signaling.
Previous studies have shown that beta-arrestin2 is required for the
regulation of Akt and GSK3 phosphorylation by lithium (O'Brien et al.,
2011). Chronic or acute exposure to lithium destabilizes the signaling
complex comprised of β-arrestin2, Akt, and PP2A that normally pro-
motes Akt dephosphorylation/inactivation. In theory, these signaling
pathways can inﬂuence both chronotropic and pro-ﬁbrotic eﬀects of
lithium. However, our ﬁndings indicated that chronic lithium treatment
does not aﬀect β-arrestin2 mRNA expression in cardiac tissues of rats.
While we did not measure β-arrestin2 protein levels or the activity
downstream kinases, it is likely that altered expression of β-arrestin2 is
not a major player in cardiac eﬀects induced by lithium treatment.
5. Conclusion
This study indicates that cardiac chronotropic hypo-responsiveness
is a consequence of chronic lithium treatment and that lithium treat-
ment leads to atrial ﬁbrosis associated with enhanced expression of
Col1a1 gene in atrial tissue. Moreover, it seems that β-arrestin2 ex-
pression is not a key player in lithium-induced cardiac eﬀects.
Fig. 2. Histological assessment of atrial tissue. Photomicrographs (40×) are shown for sections of the atria isolated from control or lithium treated rats. Atrial
sections are stained with Heamatoxylin & Eosin (A, B, and C) or Masson's trichrome (D, E and F), which stains collagen (for ﬁbrosis). Note the absence of ﬁbrosis in
control group (A). B, C, D, E and F show the histopathological features after 2 or 3months of receiving lithium. B: Mild focal interstitial ﬁbrosis. C: Subendocardial
ﬁbrosis. D: Minimal interstitial ﬁbrosis. E: Mild focal interstitial ﬁbrosis. F: Subendocardial ﬁbrosis. Arrows indicate the ﬁbrotic region. 3 rats were used in each
group. The scale bar represents 100 μm.
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